FDA Issues Trokamed Nephroscope Sheath Kidney Rupture Warning After Patient Death

Improper use of the sheaths can cause blockages, potentially leading to kidney ruptures, a complication that has been linked to at least one reported death.

Healthcare professionals are being urged not to use Trokamed Nephroscope Sheaths for certain procedures, due to a risk that the devices may cause serious injuries for patients.

The U.S. Food and Drug Administration (FDA) issued an early alert for the Trokamed Nephroscope Mini PCNL Sheaths on December 20, following multiple reports of kidney ruptures, severe injuries, and at least one death linked to the devices.

The nephroscope mini sheath is part of a nephroscope set used for minimally invasive procedures, such as examining kidneys and removing kidney stones or other kidney blockages. It is designed to bring surgical instruments, telescopes and fluids to the area undergoing surgery.

The FDA early alert is part of a pilot program recently implemented by the agency to warn the public about dangerous risks associated with medical devices before an official recall is announced.

When the agency becomes aware of a potentially high-risk device that may cause injuries to patients, the FDA will now alert the public in advance of an official recall. This effort is meant to help prevent unnecessary injuries and deaths.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The FDA warning followed an Urgent Field Safety Notice issued by Trokamed on November 26, which alerted healthcare providers to high-risk issues with certain endoscope sheaths. The notice included updated instructions clarifying that the devices should not be used for suction and irrigation procedures, a detail that was unclear in the original guidelines.

Using the sheathes for suction or irrigation may lead to reduced outflow through the shaft of the sheath due to blood, tissue and kidney stone fragments becoming lodged within it, the FDA and manufacturer warn. This can also cause pressure to build up quickly within the kidney, leading to a risk of kidney ruptures.

One death has been reported in connection to the sheath problem after a patient suffered a kidney rupture.

The manufacturer also recommends medical providers temporarily remove the nephroscope from the shaft to clear it and flush out kidney stone fragments to help prevent pressure from building up. Additionally, Trokamed issued replacement instructions for use with the updated version dated “2024-11-27.”

Devices affected by the early alert warning include: Sheath 20 Fr, 130 mm and 160 mm and Sheath 18 Fr, 130 mm and 160 mm, with Trokamed reference numbers WA2PS20S, WA2PS20L, WA2PS18S and WA2PS18L.

Affected devices include those with unique device identifiers:

  • 04251303810926
  • 04251303810919
  • 04251303810865
  • 04251303810872

The FDA is currently investigating the high-risk Trokamed Nephroscope Sheath device issue and will continue to keep the public informed as new information becomes available and if an official recall is issued.

Customers can contact Trokamed with questions about problems with the devices at k.troendle@trokamed.de or +49 770-49-2440. Reactions, side effects and other problems experienced in connection with the device should be reported to the FDA’s MedWatch Adverse Event Reporting Program.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

EU Launches Investigation Into Ozempic Vision Loss Problems
EU Launches Investigation Into Ozempic Vision Loss Problems (Posted today)

Following nearly 20 reports of vision problems from Ozempic or Wegovy since a study was published in July 2024, Danish health officials are calling for an EU investigation into the safety of semaglutide-based drugs.